TEMOZOLOMIDE AFTER RADIOTHERAPY IN RECURRENT "LOW-GRADE" DIFFUSE BRAINSTEM GLIOMA IN ADULTS

被引：0

作者：

Reyes-Botero, G. ^{[1
]}

Laigle-Donadey, F. ^{[1
]}

Mokhtari, K. ^{[1
]}

Martin-Duverneuil, N. ^{[1
]}

Delattre, J. Y. ^{[1
]}

机构：

[1] Hop La Pitie Salpetriere, Paris, France

来源：

NEURO-ONCOLOGY | 2014年 / 16卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

O8.04

引用

页数：1

共 50 条

[41] Chemotherapy and diffuse low-grade gliomas: a survey within the European Low-Grade Glioma Network [J].

Darlix, Amelie ;

Mandonnet, Emmanuel ;

Freyschlag, Christian F. ;

Pinggera, Daniel ;

Forster, Marie-Therese ;

Voss, Martin ;

Steinbach, Joachim ;

Loughrey, Carmel ;

Goodden, John ;

Banna, Giuseppe ;

Di Blasi, Concetta ;

Foroglou, Nicolas ;

Hottinger, Andreas F. ;

Baron, Marie-Helene ;

Pallud, Johan ;

Duffau, Hugues ;

Rutten, Geert-Jan ;

Almairac, Fabien ;

Fontaine, Denys ;

Taillandier, Luc ;

Viegas, Catarina Pessanha ;

Albuquerque, Luisa ;

von Campe, Gord ;

Urbanic-Purkart, Tadeja ;

Blonski, Marie .

NEURO-ONCOLOGY PRACTICE, 2019, 6 (04) :264-273

[42] The measurement of cognitive functioning in low-grade glioma patients after radiotherapy - In reply [J].

Brown, P ;

Buckner, F .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (05) :967-968

[43] Chemotherapy for diffuse low-grade gliomas in adults [J].

Ducray, F. .

REVUE NEUROLOGIQUE, 2011, 167 (10) :673-679

[44] TRAMETINIB FOR PLEXIFORM NEUROFIBROMA AND RECURRENT LOW-GRADE GLIOMA [J].

Sato, Aimee ;

Millard, Nathan ;

Perez, Francisco ;

Vitanza, Nicholas ;

Leary, Sarah .

NEURO-ONCOLOGY, 2020, 22 :420-420

[45] CT FINDING OF RECURRENT LOW-GRADE GLIOMA IN CHILDREN [J].

MOROTA, N ;

SAKAMOTO, K ;

KOBAYASHI, N ;

HASHIMOTO, K .

NEURORADIOLOGY, 1988, 30 (05) :451-451

[46] Predictors of Early and Recurrent Seizure in Low-Grade Glioma [J].

Jo, Jasmin ;

Nevel, Kathryn ;

Sutyla, Ryan ;

Smolkin, Mark ;

Lopes, M. Beatriz ;

Schiff, David .

NEUROLOGY, 2018, 90

[47] Treatment of adults with recurrent progressive low-grade glioma using imatinib mesylate and hydroxyurea [J].

Salacz, M. E. ;

Desjardins, A. ;

Quinn, J. A. ;

Rich, J. N. ;

Vredenburgh, J. J. ;

Sathornsumetee, S. ;

Goli, K. ;

Friedman, H. S. ;

Reardon, D. A. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)

[48] Early metabolic responses in temozolomide treated low-grade glioma patients [J].

Wyss, Matthias ;

Hofer, Silvia ;

Bruehlmeier, Matthias ;

Hefti, Martin ;

Uhlmann, Catrina ;

Baertschi, Esther ;

Buettner, Ulrich Wolf ;

Roelcke, Ulrich .

JOURNAL OF NEURO-ONCOLOGY, 2009, 95 (01) :87-93

[49] Phase II trial of temozolomide in patients with progressive low-grade glioma [J].

Quinn, JA ;

Reardon, DA ;

Friedman, AH ;

Rich, JN ;

Sampson, JH ;

Provenzale, JM ;

McLendon, RE ;

Gururangan, S ;

Bigner, DD ;

Herndon, JE ;

Avgeropoulos, N ;

Finlay, J ;

Tourt-Uhlig, S ;

Affronti, ML ;

Evans, B ;

Stafford-Fox, V ;

Zaknoen, S ;

Friedman, HS .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (04) :646-651

[50] A phase II study of prolonged daily temozolomide for low-grade glioma [J].

Wen, PY ;

Schiff, D ;

Doherty, L ;

Gigas, D ;

Musikansky, A ;

Bradshaw, J ;

Levy, B ;

Kesari, S ;

Ramakrishna, N ;

Maher, E ;

Black, P .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) :119S-119S

← 1 2 3 4 5 →